| Literature DB >> 1367959 |
Abstract
Recent studies have generated data demonstrating significant clinical activity of alpha-interferon therapy in each of six hematological malignancies, chronic myeloid leukaemia, essential thrombocythemia, polycythemia rubra vera, non-Hodgkin's lymphomas, multiple myelomatosis and hairy cell leukaemia.Entities:
Mesh：
Substances：
Year: 1991 PMID： 1367959 DOI： 10.1016/s0958-1669(05)80119-3
Source DB: PubMed Journal: Curr Opin Biotechnol ISSN： 0958-1669 Impact factor: 9.740